Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Phillips (PHG) integrates AI and 3D mapping capabilities it its Mobile C-Arm System, Zenition, enhancing its diagnostic imaging portfolio.

Phillips (PHG) Blends 3D Mapping With Zenition, Aids Prospects

Philips supports the American Heart Association's efforts to raise awareness of cardiovascular implantable electronic device (CIED) infections, promote guideline adherence, and improve patient survival rates

Philips integrates cloud-based AI and 3D mapping into its Mobile C-arm System Series – Zenition – to enhance workflow efficiency and improve endovascular treatment outcomes

Increased provisions for a product recall and the pandemic's impact on the installation of its medical equipment hurt the company in the fourth quarter.

Why Shares of Royal Philips Got Crushed Today

Philips (PHG) fourth-quarter and 2021 results suffer from supply-chain constraints and adverse impact of the Respironics recall.

Philips' (PHG) Q4 Earnings Hit By Supply-Chain Issues, Recall

The U.S.-listed shares of Koninklijke Philips N.V. PHG, -15.53% PHIA, -15.37% plunged 15.7% toward a near two-year low in morning trading Wednesday, after the Netherlands-based medical technologies and products company provided a downbeat revenue outlook, citing "intensified global supply chain shortages" and the postponement of customer equipment installations.

Philips stock tumbles toward biggest selloff since 2008 after downbeat revenue outlook

The shares of Koninklijke Philips NV (NYSE:PHG) are plummeting today, down 14.9% to trade at $32.97, after the medical equipment company issued a profit warning, saying it expected fourth-quarter core profit to drop nearly 40% amid supply issues.

Medical Equipment Stock Drops on Profit Warning, Recall Concerns

Shares of Koninklijke Philips NV (NYSE: PHG) slipped nearly 20% this morning after the health technology company predicted a 40% decline in Q4 core profit. Philips blames supply constraints Philips now forecast roughly $5.57 billion in comparable sales for its fiscal fourth quarter that translates to nearly $0.40 billion lower than its previous estimate.

Philips opened 15% down on Wednesday: here's the catalyst

There is some evidence that the worst of supply chain disruptions are over. For Philips, that couldn't be further from the truth.

Sonicare Maker Philips' Stock Plunges on Supply Chain Issues

Koninklijke Philips NV (NYSE: PHG) shares plunged more than 16% on Wednesday morning after the company hiked the cost of its recall of ventilators and warned earnings would take a big hit from global supply chain shortages. Philips expects the Q4 Adjusted EBITA to drop almost 43% Y/Y to about €650 million.

Philips Q4 Profit Hit By Supply Chain Shortage, Product Recalls

Dutch health technology company Philips on Wednesday said it expected fourth-quarter core profit to drop around 40% to about 650 million euros ($739.25 million), hit by a global shortage of electronic components and the fallout of a massive recall of ventilators.

Philips Q4 earnings hit by part shortages and ventilator recall

Philips provides update on its financial performance in Q4 2021

Aptiv Holdings Ltd

Sun Country Airlines

APTV, PHG, and SNCY have been added to the Zacks Rank #5 (Strong Sell) List on January 7, 2022

New Strong Sell Stocks for January 7th

Philips completes cancellation of 33.5 million shares

Phillips (PHG) signed a long-term agreement with IJsselland Hospital to facilitate digitization and innovation in healthcare.

Phillips' (PHG) Partner Base Expansion Drives Prospects

Philips and IJsselland Hospital sign long-term technology partnership

Philips provides update on the test and research program in connection with the CPAP, BiPAP and Mechanical Ventilator recall notification*

The FDA has authorized the first laser-based device to remove IVC filters, developed by Koninklijke Philips NV (NYSE: PHG). Authorization was given through the de novo pathway, with Philips' device receiving FDA breakthrough device designation for removing IVC (inferior vena cava) filters.

Philips' Device For Inferior Vena Cava Filter Removal Scores FDA Approval

Philips receives FDA De Novo Clearance for IVC Filter Removal Laser Sheath - CavaClear - with Breakthrough Device Designation

Amedisys

Altice USA

Chegg

CRISPR Therapeutics

Frontdoor Inc.

Open Lending Corp

Pan American Silver

Pinterest

StoneCo

If you're looking for bargain stocks to buy that are down 30% or more in 2021, that's not an easy task. Here are 10 that fit the bill.

10 Bargain Stocks to Buy After Falling 30% in 2021

Philips (PHG) is set to acquire Vesper Medical to strengthen its vascular devices portfolio and customer base.

Philips (PHG) to Buy Vesper Medical, Expand Vascular Portfolio

Philips provides update on composition of its Supervisory Board

Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) a leading health technology company, today announced that it has been named one of the “Top Places to Work” in Massachusetts in the 14th annual employee-based survey project from The Boston Globe. Philips, with its Innovation Center and North America Headquarters based in Cambridge, ranked 20th in the “Largest” company category. For the full rankings, visit Top Places to Work 2021. Top Places to Work recognizes the most adm

The Boston Globe Names Philips a Top Place to Work for 2021

Philips introduces fully integrated echocardiography experience, bringing together new transducer technology, AI-driven automated measurements and remote access at EuroEcho 2021

News for Royal Philips Stock (PHG)